Page last updated: 2024-09-03

1,3,4-thiadiazole and Granulocytic Leukemia, Chronic

1,3,4-thiadiazole has been researched along with Granulocytic Leukemia, Chronic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ali, TFS; Altıntop, MD; Ciftci, HI; Fujita, M; Kaplancıklı, ZA; Koga, R; Otsuka, M; Özdemir, A; Radwan, MO; Sever, B1

Other Studies

1 other study(ies) available for 1,3,4-thiadiazole and Granulocytic Leukemia, Chronic

ArticleYear
Design, Synthesis, and Biological Evaluation of Novel 1,3,4-Thiadiazole Derivatives as Potential Antitumor Agents against Chronic Myelogenous Leukemia: Striking Effect of Nitrothiazole Moiety.
    Molecules (Basel, Switzerland), 2017, Dec-27, Volume: 23, Issue:1

    Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Fusion Proteins, bcr-abl; Humans; Hydrophobic and Hydrophilic Interactions; Inhibitory Concentration 50; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetic Resonance Spectroscopy; Models, Molecular; Protein Binding; Spectrometry, Mass, Electrospray Ionization; Thiadiazoles

2017